As a result of Halo Pharmaceutical's partnership with DeMelleBioPharma, George Bobotas has joined Halo as chief scientific officer. Bobotas has been president and managing partner of DeMelleBioPharma since 2008. Prior to that, Bobotas worked for Reliant Pharmaceuticals as VP, scientific affairs.
Contract sales firm PDI has announced the appointment of David Kerr to senior vice president of business development. Kerr was most recently SVP of commercial business at Endo Pharmaceuticals.